Pharmacovigilance of Regenerative Medicine Under the Amended Pharmaceutical Affairs Act in Japan
Crossref DOI link: https://doi.org/10.1007/s40264-017-0517-2
Published Online: 2017-03-15
Published Print: 2017-06
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Inokuma, Yasuko
License valid from 2017-03-15